Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism

European Journal of Surgery

Volumn 163, Issue 5, 1997, Pages 331-337

  Farnebo, Filip ^a   Farnebo, Lars Ove ^a   Nordenström, Jörgen ^a   Larsson, Catharina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clonality; Loss of heterozygosity; Multiple endocrine neoplasia type 1; Neck exploration; Parathyroid hyperplasia; Tumour suppressor gene; Vitamin D

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CHROMOSOME 11; CHRONIC GLOMERULONEPHRITIS; CHRONIC PYELONEPHRITIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; DNA DETERMINATION; FEMALE; HUMAN; HYPERCALCEMIA; HYPOPHOSPHATEMIA; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBERCULOSIS; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; DISEASE PROGRESSION; FEMALE; HETEROZYGOTE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; MALE; MIDDLE AGED; PARATHYROID GLANDS;

EID: 0030853390     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ahmed KY, Varghese Z, Lange MJ, Lawrence DAS, Moorhead JF. Tertiary hyperparathyroidism with adenoma formation after renal transplantation. BMJ 1978; 7: 92-93.
2. Arnold A, Brown M, Ureña P, Gaz R, Sarfati E, Drüeke T. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2047-2053.
3. Bergerheim U, Nordenskjöld M, Collins V. Deletion mapping in renal carcinoma. Cancer Res 1989; 49: 1390-1396.
4. Black W, Utley J. The differential diagnosis of parathyroid adenoma and chief cell hyperplasia. Am J Clin Pathol 1968; 49: 761-775.
5. Byström C, Larsson C, Blomberg C, et al. Localization of the MEN 1 gene to a small region of chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 1990; 87: 1968-1972.
6. Falchetti A, Bale AE, Amorosi A, et al. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 1993; 76: 139-144.
7. Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature 1970; 228: 764-766.
8. Friedman E, Sakaguchi K, Bale AE, et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia Type 1. N Engl J Med 1989; 321: 213-218.
9. Golden A, Canary JJ, Kerwin DM. Concurrence of hyperplasia and neoplasia of the parathyroid glands. Am J Med 1965; 38: 562-578.
10. Krause M, Hedinger C. Pathologic study of parathyroid glands in tertiary hyperparathyroidism. Hum Pathol 1985; 16: 772-784.
11. Larsson C, Byström C, Skoog L, Rotstein S, Nordenskjöld M. Genomic alterations in human breast carcinomas. Genes Chrom Cancer 1990; 2: 191-197.
12. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type I gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85-87.
13. Lloyd HM, Parfitt AM, Jacobi JM, et al. The parathyroid glands in chronic renal failure: a study of their growth and other properties, based on findings in hypercalcemia patients. J Lab Clin Med 1989; 114: 358-367.
14. Nygren P, Larsson R, Johansson H, Ljunghall S, Rastad J, Åkerström G. 1,25(OH)2D inhibits hormone secretion and proliferation but not functional differentiation in bovine parathyroid cells. Calcif Tissue Int 1988; 42: 213-218.
15. Parfitt A. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 1982; 8: 92-112.
16. Parfitt AM. 1994 Parathyroid growth. Normal and abnormal. In: Bilezekian JP, Marcus R, and Levine MA eds. The parathyroids. New York: Raven Press, 1994: 373-405.
17. Sandelin K, Larsson C, Falkmer U, Farnebo L-O, Grimelius L, Nordenskjöld M. Morphology, DNA ploidy, and allele losses on chromosome 11 in sporadic hyperparathyroidism and that associated with multiple endocrine neoplasia, type 1. Eur J Surg 1992; 158: 199-206.
18. Silver J, Russell J, Sherwood LM. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985; 82: 4270-4273.
19. Slatopolsky E, Lopez-Hilker S, Delmez J, Dusso A, Brown A, Martin KJ. The parathyroid-calcitriol axis in health and chronic renal failure. Kidney Int 1990; 38: S41-S47.
20. Slatopolsky EC, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-2143.
21. Stanbury SW, Lumb GA. Parathyroid function in chronic renal failure. Q J Med 1966; 35: 1-23.
22. Thakker R, Bouleaux P, Wooding C, et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989; 321: 218-224.